Neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine serum
K Uriu, I Kimura, K Shirakawa… - … England Journal of …, 2021 - Mass Medical Soc
New England Journal of Medicine, 2021•Mass Medical Soc
Neutralization of the SARS-CoV-2 Mu Variant The mu variant of SARS-CoV-2 was 10.6
times as resistant to neutralization by serum samples obtained from persons who had
recovered from Covid-19 as the B. 1 lineage virus and 9.1 times as resistant to neutralization
by serum samples from persons who had received the BNT162b2 vaccine.
times as resistant to neutralization by serum samples obtained from persons who had
recovered from Covid-19 as the B. 1 lineage virus and 9.1 times as resistant to neutralization
by serum samples from persons who had received the BNT162b2 vaccine.
Neutralization of the SARS-CoV-2 Mu Variant
The mu variant of SARS-CoV-2 was 10.6 times as resistant to neutralization by serum samples obtained from persons who had recovered from Covid-19 as the B.1 lineage virus and 9.1 times as resistant to neutralization by serum samples from persons who had received the BNT162b2 vaccine.
The New England Journal Of Medicine